AI Assistant
Blog
Pricing
Log In
Sign Up
Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
